142 related articles for article (PubMed ID: 6084762)
1. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
[TBL] [Abstract][Full Text] [Related]
3. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
Liang CS; Gavras H; Hood WB
J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
[TBL] [Abstract][Full Text] [Related]
5. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Nakazawa M; Ishihara T; Takahashi Y; Okuhira M; Imai S
J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
[TBL] [Abstract][Full Text] [Related]
6. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
7. Effect of ACE-Inhibition on regional blood flow during acute left ventricular failure in the dog. Preliminary report.
Hall C; Mørkrid L; Kjekshus J
Scand J Urol Nephrol Suppl; 1984; 79():121-4. PubMed ID: 6089310
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
Nekooeian AA; Ogilvie RI; Zborowska-Sluis D
Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
[TBL] [Abstract][Full Text] [Related]
10. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Evans MA; Burnett JC; Redfield MM
J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
16. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic and hormonal effects of MK-521 in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
Scand J Urol Nephrol Suppl; 1984; 79():125-7. PubMed ID: 6089311
[TBL] [Abstract][Full Text] [Related]
18. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Trippodo NC; Fox M; Natarajan V; Panchal BC; Dorso CR; Asaad MM
J Pharmacol Exp Ther; 1993 Oct; 267(1):108-16. PubMed ID: 8229737
[TBL] [Abstract][Full Text] [Related]
20. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
